Lyra Therapeutics (LYRA) Earnings Date, Estimates & Call Transcripts $0.74 +0.09 (+13.62%) As of 05/19/2026 03:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyra Therapeutics Earnings Summary Lyra Therapeutics posted Q3 2025 earnings on November 12, 2025, reporting an EPS of -$3.38, which beat the consensus estimate of -$5.98 by $2.60. Quarterly revenue was reported to be $0.03 million, below analysts' expectations of $0.21 million. With a trailing EPS of -$19.15, Lyra Therapeutics' earnings are expected to grow next year, from ($0.93) to ($0.58) per share. Latest Q3 Earnings DateNov. 12EstimatedConsensus EPS (Nov. 12) -$5.98 Actual EPS (Nov. 12) -$3.38 Beat By $2.60 Actual Revenue (Nov. 12) $0.03MQ3 2025 Earnings ResourcesQ3 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)Powered by Get Lyra Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lyra Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataLYRA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LYRA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Lyra Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20261-$1.36-$1.36-$1.36Q2 20261-$1.54-$1.54-$1.54Q3 20261-$1.63-$1.63-$1.63Q4 20261-$1.73-$1.73-$1.73 Lyra Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/12/2025Q3 2025-$5.98-$3.38+$2.60-$3.38$0.21M$0.03M8/12/2025Q2 2025-$5.79-$5.51+$0.28-$5.51$0.18M$0.29M5/6/2025Q1 2025-$7.50-$6.00+$1.50-$0.13$0.16M$0.18M3/13/2025Q4 2024-$6.00-$8.00 -$2.00-$0.16$0.21M$0.21M8/14/2024Q2 2024-$17.00-$14.50+$2.50$0.16$0.43M$0.60M Data powered by Fiscal.ai. Lyra Therapeutics Earnings - Frequently Asked Questions When did Lyra Therapeutics announce their last quarterly earnings? Lyra Therapeutics (NASDAQ:LYRA) last announced its quarterly earning data on Wednesday, November 12, 2025. Learn more on LYRA's earnings history. Did Lyra Therapeutics beat their earnings estimates last quarter? In the previous quarter, Lyra Therapeutics (NASDAQ:LYRA) reported ($3.38) earnings per share (EPS) to beat the analysts' consensus estimate of ($5.98) by $2.60. Learn more on analysts' earnings estimate vs. LYRA's actual earnings. How much revenue does Lyra Therapeutics generate each year? Lyra Therapeutics (NASDAQ:LYRA) has a recorded annual revenue of $600,000.00. How much profit does Lyra Therapeutics generate each year? Lyra Therapeutics (NASDAQ:LYRA) has a recorded net income of -$93.43 million. LYRA has generated -$19.15 earnings per share over the last four quarters. What is Lyra Therapeutics' EPS forecast for next year? Lyra Therapeutics' earnings are expected to grow from ($0.93) per share to ($0.58) per share in the next year. More Earnings Resources from MarketBeat Related Companies NexGel Earnings Nanovibronix Earnings Vicarious Surgical Earnings Aethlon Medical Earnings Valion Bio, Inc. Common Stock Earnings INVO Fertility Earnings Nuwellis Earnings Autonomix Medical Earnings Bone Biologics Earnings Profusa Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Why Home Depot’s Sell-Off Could Become a Huge OpportunityBrady Corp Wires Up a Massive AI-Powered BreakoutDillard’s Posted a Huge Earnings Beat—So Why Did the Rally Fade?Why Applied Optoelectronics Stock May Be Near a Turning PointIs Everspin Technologies the Next AI Edge Breakout?Peloton Stock Gives Back Gains After Upbeat Earnings ReportDatavault Gains Traction: 5 Reasons to Sell Now This page (NASDAQ:LYRA) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredYour book attachedVeteran trader Bill Poulos is giving away his 'Simple Options Trading For Beginners' book - normally $29.97 - ...Profits Run | SponsoredThe one number Musk can't hide in the S-1When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...Behind the Markets | SponsoredHe doesn't buy gold. He just profits from it.Former hedge fund manager Larry Benedict generated $274 million in profits - and Barron's ranked his fund in t...Brownstone Research | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
